CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	6 Months Ended
	Feb. 28, 2025	Feb. 29, 2024
Cash flows from operating activities:
Net loss	$ (4,640)	$ (12,600)
Adjustments to reconcile net loss to net cash used for operating activities:
Depreciation and amortization	1,236	1,230
Deferred income taxes	(54)	(1,331)
Stock compensation expense	59	99
Earnings from equity method investments	(29)	(137)
Impairment of goodwill, intangibles and long-lived assets	5,660	13,589
Gain on sale of equity method investments	(391)	(758)
Gain on sale-leaseback transactions	0	(258)
(Gain) loss on variable prepaid forward contracts	(777)	888
Other	(79)	(121)
Changes in certain assets and liabilities:
Accounts receivable, net	(188)	(850)
Inventories	367	(279)
Other current assets	46	53
Trade accounts payable	(627)	142
Accrued expenses and other liabilities	(180)	20
Income taxes	(297)	256
Accrued litigation obligations	(235)	(391)
Other non-current assets and liabilities	(212)	(471)
Net cash used for operating activities	(339)	(918)
Cash flows from investing activities:
Additions to property, plant and equipment	(503)	(858)
Proceeds from sale-leaseback transactions	1	727
Proceeds from sale of other assets	769	1,311
Business, investment and asset acquisitions, net of cash acquired	(25)	(228)
Other	99	(50)
Net cash provided by investing activities	342	902
Cash flows from financing activities:
Net change in short-term debt with maturities of 3 months or less	0	426
Proceeds from debt	14,568	15,001
Payments of debt	(16,046)	(14,948)
Proceeds from variable prepaid forward contracts	0	424
Treasury stock purchases	(36)	(69)
Cash dividends paid	(432)	(828)
Other	(27)	(132)
Net cash used for financing activities	(1,973)	(127)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(8)	2
Changes in cash, cash equivalents and restricted cash:
Net decrease in cash, cash equivalents and restricted cash	(1,978)	(142)
Cash, cash equivalents and restricted cash at beginning of period	3,218	856
Cash, cash equivalents and restricted cash at end of period	$ 1,241	$ 715